Ciba-Geigy's Ritalin
Executive Summary
Drug Enforcement Administration production limits on the Schedule II drug (methylphenidate) were reduced 14% for 1988, after five years in which production had increased from just over 1,100 to 1,800 kilograms per year, according to a Citizens Commission on Human Rights, which is seeking further reductions in the DEA ceiling. The organization, established by the Church of Scientology, was on Capitol Hill April 12 to protest federal funding tied to mental illness diagnoses of inattentive children. Such diagnoses in children have increased 1,000% over the past five years, the group contends, adding that many children inappropriately have received Ritalin and experienced adverse reactions.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.